Wound Care Biologics Market Report 2026

Wound Care Biologics Market Overview

• Wound Care Biologics market size has reached to $2.06 billion in 2025 • Expected to grow to $3.19 billion in 2030 at a compound annual growth rate (CAGR) of 9.2% • Growth Driver: Rising Prevalence Of Diabetes To Drive Market Growth • Market Trend: Innovations In Wound Care Biologics Advancements In Bioengineered Synthetic Polymer Matrices Enhance Healing Efficacy • North America was the largest region in 2025 and Asia-pacific is the fastest growing region.

What Is Covered Under Wound Care Biologics Market?

Wound care biologics are bioengineered products used for non-healing wounds of the lower extremity. These biologics are gaining recognition in wound care because they effectively control secretions and protect against bacterial infection. The main products of wound care biologics are biologic skin substitutes and topical agents. Biologic skin substitutes are utilized for wound healing and have proven to be quite beneficial to the medical industry. Tissue-engineered products and artificial skin are other names for biological skin substitutes. It is a biological substance that aids in wound healing by generating new tissues. The wound types that are treated by wound care biologics are ulcers, surgical, traumatic wounds, and burns, that include end users as hospitals, ASCS, burn centers, and wound clinics.

What Is The Wound Care Biologics Market Growth Forecast?

The wound care biologics market size is expected to see strong growth in the next few years. It will grow to $3.19 billion in 2030 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to advancements in biologic skin substitutes, expansion of regenerative medicine, adoption of digital wound monitoring, increased r&d investment in wound care biologics, government initiatives supporting advanced therapies. Major trends in the forecast period include advanced wound healing technologies, increased adoption of biologic skin substitutes, antimicrobial resistance management, personalized wound care solutions, integration of regenerative medicine approaches.

Global Wound Care Biologics Market Segmentation

1) By Product: Biologic Skin Substitutes, Topical Agents 2) By Wound Type: Ulcers, Surgical, Traumatic Wounds, Burns 3) By End User: Hospitals, Ambulatory Surgery Center (ACS), Burn Centers, Wound Clinics Subsegments: 1) By Biologic Skin Substitutes: Acellular Dermal Matrices, Cellular Skin Substitutes, Composite Skin Substitutes 2) By Topical Agents: Growth Factors, Antimicrobial Agents, Enzymatic Debridement Agents

What Is The Driver Of The Wound Care Biologics Market?

The high prevalence of diabetes is expected to propel the growth of the wound care biologics market in the coming future. diabetes is a chronic metabolic condition characterized by high levels of blood glucose (or blood sugar), which causes catastrophic damage to the heart, blood vessels, eyes, kidneys, and nerves over time. Biological wound care prevents volatile water loss, heat loss, protein and electrolyte loss, and contamination. They also allow autolytic debridement and produce a granular wound layer. The high prevalence of diabetes is one of the factors driving the growth of the wound care biologics market. For instance, in June 2024, according to the National Health Service (NHS), a UK-based government department, among individuals under 40, rising from 173,166 in 2022 to 216,440 in 2023. This significant growth highlights a concerning trend in this age group. The data reflects a rapid escalation in diabetes prevalence among younger populations. Therefore, the high prevalence of diabetes is driving the wound care biologics industry.

Key Players In The Global Wound Care Biologics Market

Major companies operating in the wound care biologics market are Integra Lifesciences Corporation, Organogenesis Inc., Smith and Nephew plc, Wright Medical Group NV, MiMedx Group Inc., Kerecis AG, Amnio Technology LLC, Anika Therapeutics Inc., ACell Inc., Derma Sciences Inc., Soluble Systems Pvt. Ltd., Medline Industries LP, Solsys Medical LLC, Zimmer Biomet Holdings Inc., MLM Biologics Inc., Tissue Genesis LLC, Stryker Corporation, Marine Polymer Technologies Inc., Bioventus Inc., Mölnlycke Health Care AB, Lynch Biologics LLC, Skye Biologics Holdings LLC, Osiris Therapeutics Inc., Vericel Corporation, TissueTech Inc., PolarityTE Inc., Avita Medical Limited, Celularity Inc., Human Regenerative Technologies LLC, PolyRemedy Inc.

Global Wound Care Biologics Market Trends and Insights

Major companies operating in the wound care biologics market are focusing on developing advanced materials such as bioengineered, electrospun synthetic polymer matrix to enhance wound healing efficacy and support tissue regeneration. In the wound care biologics bioengineered, electrospun synthetic polymer matrices facilitate faster wound healing and enhanced tissue regeneration by serving as a scaffold that encourages cellular migration and growth. For instance, in October 2024, Royal Biologics, a US-based orthobiologics and life science company, launched two innovative products at the symposium on advanced wound care peak powder collagen matrix, which enhances healing in various wounds by creating a gel-like barrier that supports tissue regeneration, and electrofiber 3D, a bioengineered matrix that promotes cellular migration and reduces healing times. These advancements significantly impact the wound care biologics market by meeting the growing demand for effective healing solutions.

What Are Latest Mergers And Acquisitions In The Wound Care Biologics Market?

In July 2023, Coloplast, a US-based healthcare company, acquired Kerecis for $1.3 billion. Through this acquisition, Coloplast aims to strengthen its presence in the advanced wound care market by integrating Kerecis's innovative fish skin technology. This move helps Coloplast enter the high-growth U.S. biologics sector, enhance its revenue and gross margins, and raise its long-term organic growth guidance from 7% to 9% to 8% to 10%, all while allowing Kerecis to operate as a standalone business unit. Kerecis is an Iceland-based company specializing in regenerative medicine solutions using fish skin to treat chronic wounds and surgical applications.

Regional Insights

North America was the largest region in the wound care biologics market in 2025.Asia-pacific is expected to be the fastest-growing region in the global wound care biologics market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Wound Care Biologics Market?

The wound care biologics market consists of revenues earned by entities by providing wound care services such as surgical and traumatic wounds, burns chronic wounds and acute Wounds. The market value includes the value of related goods sold by the service provider or included within the service offering. The wound care biologics market also includes sales of surgical equipment's, medical tape, sponges, cotton pads which are used in providing wound care biologics services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Wound Care Biologics Market Report 2026?

The wound care biologics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the wound care biologics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.